We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$1.22B
AUM Growth
+$236M
Cap. Flow
+$242M
Cap. Flow %
19.95%
Top 10 Hldgs %
10.08%
Holding
636
New
201
Increased
78
Reduced
62
Closed
295

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.2M
2
DVN icon
Devon Energy
DVN
+$12.8M
3
ULTA icon
Ulta Beauty
ULTA
+$12.7M
4
GS icon
Goldman Sachs
GS
+$12.7M
5
MNST icon
Monster Beverage
MNST
+$11.6M

Top Sells

Rank Stock Value
1
NTNX icon
Nutanix
NTNX
+$10.6M
2
LUV icon
Southwest Airlines
LUV
+$10.2M
3
XOM icon
ExxonMobil
XOM
+$10.2M
4
COST icon
Costco
COST
+$9.96M
5
PPL
PPL Corp
PPL
+$9.81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.31%
2 Technology 17.79%
3 Financials 12.54%
4 Healthcare 11.75%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGC icon
376
BGC Group
BGC
$5.52B
-202,617
Closed -$1.97M
BHC icon
377
Bausch Health
BHC
$2.57B
-137,217
Closed -$2.85M
BKU icon
378
Bankunited
BKU
$3.37B
-12,900
Closed -$525K
BMA icon
379
Banco Macro
BMA
$5.88B
-28,500
Closed -$3.3M
BMY icon
380
Bristol-Myers Squibb
BMY
$133B
-104,059
Closed -$6.38M
BPMC
381
DELISTED
Blueprint Medicines
BPMC
-10,100
Closed -$762K
BPOP icon
382
Popular Inc
BPOP
$11.2B
-45,093
Closed -$1.6M
BSX icon
383
Boston Scientific
BSX
$69.5B
-233,591
Closed -$5.79M
BUD icon
384
AB InBev
BUD
$167B
-7,821
Closed -$873K
BWXT icon
385
BWX Technologies
BWXT
$15.5B
-6,500
Closed -$393K
CCL icon
386
Carnival Corporation Ltd
CCL
$38.1B
-40,676
Closed -$2.7M
CCK icon
387
Crown Holdings
CCK
$12.8B
-47,000
Closed -$2.64M
CGNX icon
388
Cognex
CGNX
$10.9B
-68,812
Closed -$4.21M
CMA
389
DELISTED
Comerica
CMA
-13,136
Closed -$1.14M
CMC icon
390
Commercial Metals
CMC
$7.6B
-36,000
Closed -$768K
CNC icon
391
Centene
CNC
$30.7B
-7,990
Closed -$403K
COO icon
392
Cooper Companies
COO
$14.1B
-6,800
Closed -$370K
COST icon
393
Costco
COST
$422B
-53,500
Closed -$9.96M
CPA icon
394
Copa Holdings
CPA
$5.76B
-5,660
Closed -$759K
CPRT icon
395
Copart
CPRT
$27B
-101,600
Closed -$1.1M
CPRI icon
396
Capri Holdings
CPRI
$1.83B
-59,067
Closed -$3.72M
CVE icon
397
Cenovus Energy
CVE
$55.7B
-81,980
Closed -$748K
CYBR
398
DELISTED
CyberArk
CYBR
-11,000
Closed -$455K
CZR icon
399
Caesars Entertainment
CZR
$6.06B
-23,600
Closed -$782K
DE icon
400
Deere & Co
DE
$160B
-36,228
Closed -$5.67M

Similar funds

Seven Eight Capital's Q1 2018 Portfolio in Review

As of Q1 2018, Seven Eight Capital held 636 positions worth $1.22B, up 24% from $979M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Seven Eight Capital deployed $242M of net new capital in Q1 2018, opening 201 new positions and adding to 78 existing holdings. Its largest new stake was AbbVie: 129,358 shares worth $12.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Nutanix, an estimated $10.6M trimmed.

  • Seven Eight Capital's largest Q1 2018 buy was AbbVie: 129,358 shares worth $12.2M.
  • Seven Eight Capital added most to Ulta Beauty in Q1 2018, an estimated $12.7M increase.
  • Seven Eight Capital's biggest Q1 2018 reduction was Nutanix, cutting an estimated $10.6M.
  • Seven Eight Capital fully exited Southwest Airlines in Q1 2018, selling an estimated $10.2M.
  • Seven Eight Capital's ten largest holdings make up 10% of its $1.22B portfolio in Q1 2018.
  • Seven Eight Capital opened 201 new positions and closed 295 in Q1 2018.
  • Seven Eight Capital's portfolio value rose 24% quarter-over-quarter to $1.22B.

Based on Seven Eight Capital's 13F filing for Q1 2018, filed 14 May 2018.